Preview | Issue Date | Title | Author(s) | Access |
![Non-pharmacological therapy in chronic musculoskeletal pain.pdf.jpg](/retrieve/06729c35-a4bc-4468-8fd6-f10e673682c3/Non-pharmacological%20therapy%20in%20chronic%20musculoskeletal%20pain.pdf.jpg) | Sep-2022 | Non-pharmacological therapy in chronic musculoskeletal pain | Inda, María del Mar; Margarit, César; Vara, Amaya; Cutillas, Esperanza; Mateu, Marga; Martínez, Evan; Coves, Miriam; Rodríguez, Jorge; Ballester, Purificación; Barrachina, Jordi; Morales, Domingo; Peiró, Ana | ![](/image/closedAccess.png) |
![OPRM1 influence on and effectiveness of an individualized.pdf.jpg](/retrieve/f0912f0d-190d-4252-9401-6e74eb01cbdc/OPRM1%20influence%20on%20and%20effectiveness%20of%20an%20individualized.pdf.jpg) | 2018 | OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José F. | ![](/image/closedAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | Jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Oxycodonenaloxone.naxolone versus tapentadol in real world chronic non‑cancer pain.pdf.jpg](/retrieve/6dff66a3-3891-4c74-9646-8c79f0d0e88e/Oxycodonenaloxone.naxolone%20%20versus%20tapentadol%20in%20real%20world%20chronic%20non%e2%80%91cancer%20pain.pdf.jpg) | 2022 | Oxycodone/naloxone versus tapentadol in real‑world chronic non‑cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana María | ![](/image/openAccess.png) |
![Sex Bias and Genotype Influence on Opioid.pdf.jpg](/retrieve/df0fccac-8b67-4d2d-ac33-88da66e53259/Sex%20Bias%20and%20Genotype%20Influence%20on%20Opioid.pdf.jpg) | Jul-2020 | Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back Pain | Margarit, César; Roca, Reyes; Inda, María del Mar; Muriel, Javier; Ballester, Purificación; Flor, Andrea; Morales, Domingo; Peiró, Ana | ![](/image/closedAccess.png) |
![β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease Liver cirrhosis and osteoarthritis.pdf.jpg](/retrieve/498bfe8d-d199-45c0-9bd1-987cae40fe68/%ce%b22%e2%80%91adrenergic%20receptor%20functionality%20and%20genotype%20in%20two%20different%20models%20of%20chronic%20inflammatory%20disease%20Liver%20cirrhosis%20and%20osteoarthritis.pdf.jpg) | Jun-2018 | β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis | ROCA, REYES; ESTEBAN, PABLO; Zapater, Pedro; Inda, María del Mar; CONTE, LUCIA; Gómez-Escolar, Laura ; MARTÍNEZ, HELENA; Horga, José Francisco; PALAZON, JOSÉ M.; Peiró, Ana | ![](/image/openAccess.png) |